Quantcast

Latest Pharmaceutics Stories

2014-09-29 12:28:47

CHENGDU, China, Sept. 29, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that its Qionglai Facility (QLF) has successfully completed the official site visit by the China Food & Drug Administration's (CFDA) for its Good Manufacturing Practice (GMP)...

2014-09-24 12:26:31

NEW YORK, Sept. 24, 2014 /PRNewswire/ -- The total biopharmaceutical manufacturing market is growing, according to Kalorama Information's report, Biopharmaceutical and Vaccine Production Markets. The market research publisher includes all costs related to biopharmaceutical and vaccine manufacturing in its estimates. The total global market equaled approximately $36.8 billion in 2013, with the high expense of adding biomanufacturing capacity at commercial production levels driving...

2014-09-23 12:30:16

DUBLIN, Sept. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biopharmaceutical and Vaccine Production Markets" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Though biotechnology has created many new therapies and vaccines - including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders - there are still huge challenges during the final stages of clinical drug testing for new biopharmaceuticals, as...

2014-09-23 08:32:14

COSTA MESA, Calif., Sept. 23, 2014 /PRNewswire-iReach/ -- WCCT Global, a full service contract research organization headquartered in Southern California that is known for their on-time completion of clinical trials, announced today the successful completion of a Chinese ethnobridging clinical trial. WCCT Global was asked to quickly enroll 18, 1st generation Chinese volunteers into a clinical trial which required these subjects to stay in-house for 17 days. Successful completion of...

2014-09-18 12:30:02

Liz Moench, President & CEO of MediciGroup® Inc., will Chair the Allan Lloyds Patient Recruitment and Retention Summit Asia-Emerging Markets, 2014 PHILADELPHIA and LONDON, Sept. 18, 2014 /PRNewswire/ -- It's a new era for biopharmaceutical companies. Competition for innovation, increasing clinical development costs, new technologies and a necessity to keep up with the fast-changing environment are important factors driving industry change. These factors also influence clinical trials, and...

2014-09-17 23:14:27

The Freeslate Core Module 3 Reaction Screening System will be used to advance small molecule organic chemistry research objectives Sunnyvale, CA (PRWEB) September 17, 2014 Freeslate, Inc., the leading provider of high throughput research solutions for drug development, today announced that Baylor University acquired a Freeslate Core Module 3 (CM3) Reaction Screening System to both support Baylor research interests and provide screening services to the Texas community. Freeslate’s high...

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...

2014-09-15 08:29:50

SPRINGFIELD, N.J., Sept. 15, 2014 /PRNewswire/ -- Hudson Robotics, Inc., of Springfield, NJ, in cooperation with Johns Hopkins University, has recently been awarded an NIH grant to develop a commercially viable high-throughput screening (HTS) system for in vivo studies of zebrafish. Logo - http://photos.prnewswire.com/prnh/20140912/145910 This system, termed the Automated Reporter Quantification in vivo (ARQiv) system, will bring high-throughput screening technology into the realm...

2014-09-11 20:21:43

Clinical oncology expert joins as company advances late-stage clinical programs BOULDER, Colo., Sept. 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of Victor Sandor, M.D., as Chief Medical Officer. Dr. Sandor will be responsible for leading clinical, medical and regulatory strategy and...

2014-09-10 12:28:52

-Dr. Cagnoni Joins Non-Profit Organization Focused on Fostering Innovation and Collaboration to Strengthen the Bay Area BioEconomy- SAN FRANCISCO, Sept. 10, 2014 /PRNewswire/ -- The Bay Area BioEconomy Initiative (BAB) today announced that it has named Pablo J. Cagnoni, M.D., President of Onyx Pharmaceuticals, Inc., to its Steering Committee. Onyx, an Amgen subsidiary, is engaged in the development and commercialization of innovative therapies to improve the lives of people with...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'